Vaniam Group™ Presents Data on Improving Clinical Trial Performance at the 2024 ASCO Annual Meeting
Vaniam Group CSS (Clinical Strategy and Solutions) poster focuses on “Improving Clinical Trial Performance Using Adult-Learning Methods”
Vaniam Group
Vaniam Group™ Hires Carol Scholz as Executive Vice President of Client Solutions
Ms. Scholz brings 25 years of leadership experience driving the success of oncology brands across several top pharmaceutical companies
Bio Ascend, a Vaniam Group Company, Reconvenes Inaugural Class of the “Academy of Next Wave of Investigators™” in CLL and NHL
Early-career clinical investigators continue year-long mentorship and professional development program led by international thought leaders
Women Leaders in Oncology® Presents “Woman Oncologist of the Year” Award to Dr. Julie Gralow, “Rising Star” Award to Dr. Jaydira Del Rivero
Awards presented at the 5th Annual LEAD conference for women in oncology and hematology
Vaniam Group Names Richard Neave Chief Financial Officer
Mr. Neave brings 15+ years of CFO experience within mid- to large-sized medical communications and pharma services agencies
Recognized as One of America’s Fastest-Growing Private Companies, Vaniam Group Ranks Within the Inc. 5000 for Fourth Consecutive Year
This marks the fourth consecutive year that Vaniam Group has qualified for this prestigious honor.
Promoting Diversity and Equity in Cancer Research, Women Leaders in Oncology® and Vaniam Group Announce Recipients of 2023 Young Investigator Awards
Patricia Mae Garcia Santos, MD, MS, receives annual Conquer Cancer-Women Leaders in Oncology “Women Who Conquer Cancer” Young Investigator Award and Tafadzwa L. Chaunzwa, MD, MHS, receives annual Conquer Cancer-Vaniam Group LLC Young Investigator Award, dedicated to Black, African, or African American cancer researchers
Vaniam Group Appoints Robert L. Coleman as Company’s Inaugural Chief Medical Officer
With 3 decades as a leading gynecologic oncologist, Dr. Coleman’s appointment reinforces Vaniam Group’s commitment to scientific excellence and advancing patient care.
Bio Ascend, a Vaniam Group Company, Unveils Inaugural Class of the “Academy of Next Wave of Investigators™” in CLL and NHL
Nineteen early-career clinical investigators to receive year-long mentorship and professional development program led by international thought leaders.
Vaniam Group Hires Paula Franson to Lead Clinical Strategy & Solutions
Ms. Franson will help biopharma clients design a phased approach to inform and execute clinical development plans, amplify awareness within clinician and patient communities, and form partnerships necessary to accelerate clinical trial completion.
